Videos | EP Lab

Learn about the trends and new technology in electrophysiology (EP) in an interview with David Wilber, M.D., editor of ...

Home March 25, 2015
Home
News

A new expert consensus paper released by a coalition of cardiovascular organizations provides guidance on transcatheter pulmonic valve replacement (tPVR) for children and adults who were previously treated for congenital heart disease (CHD). The paper was jointly issued by the Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC) and The Society of Thoracic Surgeons (STS).

Home March 25, 2015
Home
Bendavia, heart attack, scarring, angioplasty, ACC, study
Feature

Patients who received the new drug Bendavia before undergoing angioplasty or stent implantation after a heart attack showed no significant reduction in scarring compared to patients given a placebo, according to a new study.

Home March 25, 2015
Home
News

Mount Sinai experts were the first in the eastern United States on March 23 to implant the Watchman device, a newly U.S. Food and Drug Administration (FDA)-approved device that prevents stroke in patients with arrhythmia.

Home March 25, 2015
Home
Edwards Lifesciences, Sapien 3, Partner, ACC.15, acc 2015
Feature

he Sapien 3 heart valve (Edwards Lifesciences) demonstrated lower death, stroke and paravalvular leak rates than earlier generation devices in patients at high risk for surgery and showed encouraging results in intermediate-risk patients, according to research presented at the 2015 American College of Cardiology (ACC) Annual Scientific Session.

Home March 25, 2015
Home
News

Patients who experience the deadliest form of heart attack — ST-segment elevation myocardial infarction (STEMI) — and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the 2015 American College of Cardiology (ACC) Annual Scientific Session.

Home March 25, 2015
Home
Videos | ACC

DAIC Editor Dave Fornell shares his picks of the most interesting new devices and advances in cardiovascular technology ...

Home March 25, 2015
Home
BEST Trial
Feature

Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were opened with balloon angioplasty and stents in a study presented at the 2015 American College of Cardiology (ACC) Annual Scientific Session.

Home March 25, 2015
Home
Feature

A novel therapy that would allow doctors to turn the body’s blood clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing angioplasty but was associated with higher rates of moderate to severe bleeding, according to an analysis of data from a terminated Phase III trial presented at the American College of Cardiology’s 64th Annual Scientific Session. The study was officially halted in August due to an excess of severe allergic reactions, so authors caution that the data should be considered exploratory given the early termination.

Home March 25, 2015
Home
Technology

The U.S. Food and Drug Administration (FDA) has cleared Toshiba America Medical Systems new Infinix 4D CT system to enable computed tomography (CT) imaging directly in the cath lab. It integrates an Aquilion Prime CT system and Infinix Elite cardiovascular X-ray angiography system. The Infinix 4D CT previously received FDA clearance with the Infinix Elite cardiovascular X-ray system and Aquilion One Vision Edition CT system configuration.

Home March 25, 2015
Home
Bonn Call for Action, FDA, radiation exposure, medical imaging, update
Feature

The U.S. Food and Drug Administration (FDA) announced its latest efforts in supporting the Bonn Call for Action, an international list of priorities for radiation protection in medicine for the next decade.

Home March 25, 2015
Home
Technology

The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for Abiomed’s Impella 2.5 heart pump during elective and urgent high-risk percutaneous coronary intervention (PCI) procedures.

Home March 25, 2015
Home
TOTAL trial, thrombectomy, STEMI
Feature

Clearing blood clots (thrombectomy) from coronary arteries in about 20 percent of patients undergoing angioplasty appears to increase the risk of stroke without providing the intended benefit, according to a study presented at the 2015 American College of Cardiology (ACC) annual meeting.

Home March 24, 2015
Home
News

A study in the March 24/31 issue of JAMA found that using balloon-expandable stents to treat symptomatic intracranial arterial stenosis resulted in an increased risk of stroke or transient ischemic attack (TIA). The study results support the use of medical therapy (clopidogrel and aspirin) as an alternative to balloon-expandable stents.

Home March 24, 2015
Home
Feature

atients with atrial fibrillation (AF) who received ablation while they were already undergoing surgery to correct a leaky mitral valve had fewer episodes of AF a year later compared to patients who had the valve surgery alone. This was according to a study presented at the American College of Cardiology (ACC) 2015 meeting.

Home March 24, 2015
Home
Subscribe Now